PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2020Journal of Clinical Oncology823 citations

HER2-Low Breast Cancer: Pathological and Clinical Landscape

View Full Paper
PTPaolo TarantinoEHErika HamiltonSTSara M. Tolaney

Key Points

Key points are not available for this paper at this time.

Abstract

International audience

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tarantino et al. (2020) studied this question.

synapsesocial.com/papers/69daa8b54a1e15904c835852https://doi.org/10.1200/jco.19.02488
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A review of bispecific antibodies and antibody constructs in oncology and clinical challenges2019 · 303 citations
  2. 2Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2018 · 88,099 citations
  3. 3Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer2005 · 464 citations
  4. 4Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene1987 · 11,806 citations
  5. 5Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update2018 · 1,496 citations